MTOR and Hypoglycemia: Recently, it has been demonstrated (Bernier et al., 2020) in models of hypoglycemia or aglycemia that activities of microglia, such as process motility and damage sensing functions, are maintained by alternative metabolic pathways such as glutaminolysis, which depend on mammalian target of rapamycin (mTOR) activation.